IBS is a syndrome; it is defined by a group of symptoms, does not cause inflammation and rarely requires hospitalization or ...

Committee for Medicinal Products for Human Use (CHMP) has recommended Eli Lilly’s Omvoh (mirikizumab) for approval in the ...

Pythons may hold the answer to another way to regrow our guts, a group of researchers led by the University of Texas at Arlington finds.

A complex, chronic, and debilitating condition, inflammatory bowel disease (IBD) affects roughly 3 million Americans, including those with Crohn's disease and ulcerative colitis.

The drug has received a nod from the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP).

Eli Lilly LLY announced that the EMA’s Committee for Medicinal Products for Human Use (“CHMP”) recommended approving its ...

but it’s possible you may never have heard of Crohn’s, Colitis or inflammatory bowel disease. You may have heard of inflammatory bowel disease (IBD) but don’t really understand the difference between ...

ORLANDO -- A considerable amount of variability exists in surgical management of ileosigmoid fistulas in Crohn's disease (CD) ...

Gavin Anumene, a fan of anime, Lego and video games — as is right and proper at age 8 — has already logged more time in a ...

The Helmsley Charitable Trust issued a $3,035,566 grant to three researchers to explore the effects of GLP-1s, including Ozempic and Wegovy, on patients with Crohn’s disease. The effort will be led by ...

Inflammatory bowel disease (IBD) is a chronic inflammation of the digestive tract. It includes conditions such as ulcerative colitis and Crohn’s disease. People with IBD may experience persistent symp ...

Thankfully, the drug price reforms in the Inflation Reduction Act respond to the needs of millions of patients like myself ...